Drug Shortage Report for FENTORA

Last updated on 2025-02-03 History
Report ID 246115
Drug Identification Number 02408023
Brand name FENTORA
Common or Proper name FENTORA 400MCG BUCCAL TAB
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FENTANYL
Strength(s) 400MCG
Dosage form(s) TABLET (EFFERVESCENT)
Route of administration SUBLINGUAL BUCCAL SUBLINGUAL BUCCAL
Packaging size PP28
ATC code N02AB
ATC description OPIOIDS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2024-12-18
Estimated end date 2025-02-07
Actual end date
Shortage status Actual shortage
Updated date 2025-02-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2025-02-03 French Compare
v5 2025-02-03 English Compare
v4 2025-01-30 French Compare
v3 2025-01-30 English Compare
v2 2024-12-19 French Compare
v1 2024-12-19 English Compare

Showing 1 to 6 of 6